Frequently Asked Questions about Medpace Holdings, Inc. (MEDP)

Name: Medpace Holdings, Inc. (MEDP) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Medpace Holdings, Inc. (MEDP) do?

Accepted Answer

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical...

Question 2

Is Medpace Holdings, Inc. (MEDP) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of MEDP reveals an Altman Z-Score of 7.30 and a Piotroski F-Score of 6/9. These metrics, combined with its 5-year revenue trend ($2.53B most recent), help investors decide if MEDP fits their risk profile.

Question 3

What is the current P/E ratio for MEDP?

Accepted Answer

As of the latest trading session, Medpace Holdings, Inc. (MEDP) has a trailing P/E ratio of 30.94.

Question 4

Who is the CEO of Medpace Holdings, Inc.?

Accepted Answer

The current Chief Executive Officer of Medpace Holdings, Inc. is August James Troendle.

Question 5

What was MEDP's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Medpace Holdings, Inc. reported annual revenues of $2.53B (2025), $2.11B (2024), $1.89B (2023), $1.46B (2022), $1.14B (2021) respectively.

Question 6

Does MEDP pay a dividend?

Accepted Answer

Medpace Holdings, Inc. does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does MEDP have?

Accepted Answer

In its latest reporting period, Medpace Holdings, Inc. generated $0.68B in Free Cash Flow against a total debt load of $0.25B.

Question 8

What is the Price-to-Book (P/B) ratio of Medpace Holdings, Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for Medpace Holdings, Inc. (MEDP) is currently 30.40.

Question 9

What is the Price-to-Sales (P/S) ratio of MEDP?

Accepted Answer

Based on trailing twelve-month data, Medpace Holdings, Inc. (MEDP) trades at a Price-to-Sales (P/S) ratio of 5.57.

Question 10

What is Medpace Holdings, Inc.'s Return on Equity (ROE)?

Accepted Answer

Medpace Holdings, Inc. (MEDP) has a Return on Equity (ROE) of 118.82%, representing its profitability relative to shareholder equity.

Period	Revenue	Gross Profit	Op. Income	Net Income	EPS
2025-12	2.5B	760.6M	534.9M	451.1M	15.64
2024-12	2.1B	656.3M	446.9M	404.4M	13.06
2023-12	1.9B	524.5M	336.8M	282.8M	9.20
2022-12	1.5B	432.4M	278.7M	245.4M	7.57
2021-12	1.1B	328.2M	198.6M	181.8M	5.06